
Mariza Daras
Physician · Genesis HealthCare
Credentials: · · · · · ·
History
- 2026–Present
2009–2012

Research
Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial
Nature Medicine · 2023 · 266 citations
Phase 1b trial of an ibrutinib-based combination therapy in recurrent/refractory CNS lymphoma
Blood · 2019 · 201 citations
Cellular architecture of human brain metastases
Cell · 2022 · 181 citations

11 papers

11 papers · 11 as a resident

11 papers

10 papers

9 papers

8 papers · 7 as a fellow

8 papers

7 papers · 7 as a resident
Clinical trials
- 2018–2026
Principal investigator · Active not recruiting · Phase 1
AstraZeneca
- 2024–2028
Adagrasib + SRS for Patients With Metastatic KRAS G12C-mutated NSCLC With Untreated Brain Metastases
Site PI · Recruiting · Phase 2
Ryan Gentzler, MD


